ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1,3,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
3,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
3,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3,4,Headache,Headaches NEC,Headaches,Nerv,N
3,5,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
3,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
4,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
4,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4,4,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
4,5,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
4,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
4,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
4,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
6,1,Cerebral ventricle dilatation,Structural brain disorders NEC,Structural brain disorders,Nerv,N
6,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,Y
6,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7,1,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
7,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
7,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
7,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,12,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
8,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
8,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
9,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
10,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
10,2,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
10,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
11,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
11,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
11,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
12,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
12,2,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
13,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
13,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
13,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
14,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
14,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
14,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
14,4,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
15,1,Lung cancer metastatic,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
15,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
15,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
16,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
18,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
19,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
20,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
20,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
21,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
22,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
23,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
24,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
24,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
24,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
24,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
25,1,Anal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
25,2,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
25,3,Genital ulceration,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
26,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,2,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
27,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
27,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
27,3,Temporal lobe epilepsy,Partial complex seizures,Seizures (incl subtypes),Nerv,N
28,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
28,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
29,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
30,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
30,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
30,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
31,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
31,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
31,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
31,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
31,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
31,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
31,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
31,8,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
31,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
31,10,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
32,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
32,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
33,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
34,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
34,2,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
35,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
36,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
36,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
37,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
37,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
38,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
39,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
39,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
40,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
40,2,Noninfective gingivitis,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
41,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
41,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
41,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
42,1,Adenoid cystic carcinoma of salivary gland,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
42,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
42,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
43,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
43,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
43,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
43,4,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
43,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
43,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
43,7,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
43,8,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
43,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
44,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
45,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
45,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
45,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
46,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
46,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
46,3,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
47,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
47,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
48,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
48,2,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
48,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
49,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
49,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
49,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
49,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
50,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
50,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
50,3,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
51,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
51,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
52,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
53,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
53,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
53,3,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
54,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
55,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
55,2,Embolic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
56,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
56,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
56,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
57,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
58,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
58,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
59,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
60,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
61,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
61,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
62,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
62,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
62,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
63,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
63,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
64,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
65,1,Dermatitis infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
66,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
67,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
67,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
67,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
67,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
68,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
68,2,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
68,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
69,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
69,2,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
70,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
71,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
71,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
71,3,Embolic cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
71,4,Meningioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
72,1,Brain cancer metastatic,Central nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
72,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
72,3,Human epidermal growth factor receptor negative,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
73,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
74,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
74,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
74,3,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
74,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
74,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
75,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
75,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
75,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
75,4,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
75,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
75,6,Wrong drug,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
76,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
76,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
76,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
76,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
76,5,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
77,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
78,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
79,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
79,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
79,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
80,1,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
81,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
81,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
81,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
82,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
82,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
82,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
82,4,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
83,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
84,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
85,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
86,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
86,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
87,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
87,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
87,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
87,4,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
87,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
87,6,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
87,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
88,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
88,2,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
88,3,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
89,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
90,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,Y
90,2,Gastrointestinal necrosis,Gastrointestinal necrosis and gangrene (excl gangrenous hernia),Gastrointestinal vascular conditions,Gastr,N
90,3,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
90,4,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
90,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
90,6,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
91,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
91,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
92,1,Cerebral calcification,Structural brain disorders NEC,Structural brain disorders,Nerv,N
92,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
92,3,Neurological decompensation,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,Y
92,4,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
92,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
93,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
93,2,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
93,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
94,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
94,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
94,3,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
94,4,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
95,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
96,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
96,2,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
97,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
98,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
99,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
100,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
101,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
101,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
101,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
101,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
102,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
102,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
102,3,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
103,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
104,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
105,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
106,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
108,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
109,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
110,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
110,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
111,1,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
112,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
113,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
113,2,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
114,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
114,2,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
114,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
115,1,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
116,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
116,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
116,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
116,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
117,1,Thyroidectomy,Thyroid therapeutic procedures,Endocrine gland therapeutic procedures,Surg,N
118,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
119,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
120,1,Paternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
121,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
